Jump to main content
Jump to site search

Issue 11, 2018
Previous Article Next Article

Some activities of PorphyChem illustrated by the applications of porphyrinoids in PDT, PIT and PDI

Author affiliations

Abstract

Photodynamic therapy is an innovative approach to treat diverse cancers and diseases that involves the use of photosensitizing agents along with light of an appropriate wavelength to generate cytotoxic reactive oxygen species. Among the collection of potential dye candidates, porphyrinoids (i.e. porphyrins, chlorins, and phthalocyanines) are probably the most promising photosensitizers for PDT applications. This review shows the great potential of these derivatives for their industrial development in the field of health through different applications in photodynamic therapy (PDT), photoimmunotherapy (PIT), ophthalmology, dermatology and photodynamic inactivation (PDI). The purpose of this survey is also to show the new trends and evolutions in these fields.

Graphical abstract: Some activities of PorphyChem illustrated by the applications of porphyrinoids in PDT, PIT and PDI

Back to tab navigation

Publication details

The article was received on 04 Jun 2018, accepted on 04 Aug 2018 and first published on 15 Aug 2018


Article type: Perspective
DOI: 10.1039/C8PP00222C
Citation: Photochem. Photobiol. Sci., 2018,17, 1675-1690
  •   Request permissions

    Some activities of PorphyChem illustrated by the applications of porphyrinoids in PDT, PIT and PDI

    B. Habermeyer and R. Guilard, Photochem. Photobiol. Sci., 2018, 17, 1675
    DOI: 10.1039/C8PP00222C

Search articles by author

Spotlight

Advertisements